- Patent Title: Rapidly disintegrating solid oral dosage forms containing dasatinib
-
Application No.: US17004146Application Date: 2020-08-27
-
Publication No.: US10894017B1Publication Date: 2021-01-19
- Inventor: Per Andersson , Thomas Meijer , Victor Söderberg
- Applicant: XSPRAY PHARMA AB
- Applicant Address: SE Solna
- Assignee: XSPRAY PHARMA AB
- Current Assignee: XSPRAY PHARMA AB
- Current Assignee Address: SE Solna
- Agency: Merchant & Gould P.C.
- Agent Daniel R. Evans
- Main IPC: A61K9/20
- IPC: A61K9/20 ; A61K31/506 ; A61K9/00 ; A61K9/28
Abstract:
The instant application relates to the field of pharmaceutical compositions comprising dasatinb. Furthermore, the instant application relates to a method of treating proliferative disorders in a patient in need thereof, comprising administering a therapeutically effective amount of said compositions.
Information query
